other

Managing Severe Sepsis in the ICU: The Clinical Synergy of PCT and IL-6 Testing

Home Blog Blog

Managing Severe Sepsis in the ICU: The Clinical Synergy of PCT and IL-6 Testing

Managing Severe Sepsis in the ICU: The Clinical Synergy of PCT and IL-6 Testing
June 26, 2026

 

1. Introduction

Sepsis is a medical emergency in which rapid assessment and repeated reassessment are essential. No single laboratory marker can confirm or exclude sepsis, but complementary biomarkers can add objective information while clinicians evaluate infection, organ dysfunction, microbiology, imaging and source control.

 

PCT and IL-6 provide different views of the host response. IL-6 reflects early inflammatory activation, while PCT is more closely associated with systemic bacterial infection and often remains elevated longer. Used together and interpreted as trends, they can support a clearer picture of disease evolution in the ICU.

 

2. Why PCT and IL-6 Work Better Together

The value of combined testing comes from complementary timing and clinical interpretation rather than from a single universal cut-off.

 

 

Marker

What it adds

Key limitation

IL-6

Early signal of cytokine-driven inflammation; useful for severity context and rapid change over time.Also valuable in COVID-19 severity stratification and cytokine release syndrome (CRS) monitoring.

 

Sensitive but not specific for bacterial infection; may rise after surgery, trauma or other inflammatory stress.

PCT

Adds context for systemic bacterial infection and is useful for serial monitoring and antimicrobial review.

May remain low in very early or localized infection and can be influenced by timing, renal dysfunction and major tissue injury.

 

 

PCT and IL-6

 

Practical interpretation  Focus on direction of change. A persistent or secondary rise should prompt reassessment for uncontrolled infection, inadequate source control, complications or a non-infectious inflammatory process.

 

3. A Practical ICU Testing Framework

 

At presentation

Clinical exam, cultures, lactate, organ-function assessment + baseline PCT and IL-6

624 hours

Repeat biomarkers when clinically indicated; focus on direction and rate of change

Ongoing ICU review

Integrate trends with source control, microbiology, hemodynamics and response to therapy

Antibiotic review

Use PCT only with clinical evaluation; never as the sole reason to start or stop treatment

 

4. Poclight C5000 Assay Information

 

Assay

Sample

Volume

Time

Measuring range

Storage / stability

PCT

Serum / Plasma

200 µL

5 min

0.02-100 ng/mL

2-30°C / 18 months

IL-6

Serum / Plasma

100 µL

15 min

1.5-5000 pg/mL

2-30°C / 18 months

 

Our standout features:

 

1.  Small Sample Volume & Rapid Results

Small sample volume of serum or plasma needed, with 5-15 minute turnaround, ideal for fast clinical decisions.

2.  Freeze-dried reagents: no cold chain, 18 months shelf life, simplifying storage and transport.

3.  High accuracy and excellent precision (CV < 5%)

4.  Applicable with the C5000 POC CLIA Analyzer: 3-Step Operation, Maintenance-Free

Leave A Message

Leave A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
Submit

Home

Products

WhatsApp

contact